These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30811214)

  • 1. Calcineurin Inhibitors and Variation in the Performance of Interferon-γ Release Assays Used to Detect Tuberculosis Infection.
    Barton E; Gao Y; Ball D; Fidler K; Klein N; Curtis N; Clifford V; Marshall BG; Chancellor A; Mansour S; Elkington P; Tebruegge M
    Ann Am Thorac Soc; 2019 Jun; 16(6):771-775. PubMed ID: 30811214
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticosteroids and infliximab impair the performance of interferon-γ release assays used for diagnosis of latent tuberculosis.
    Edwards A; Gao Y; Allan RN; Ball D; de Graaf H; Coelho T; Clifford V; Curtis N; Williams A; Faust SN; Mansour S; Marshall B; Elkington P; Tebruegge M
    Thorax; 2017 Oct; 72(10):946-949. PubMed ID: 28159773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes.
    Chang KT; Lin HY; Kuo CH; Hung CH
    J Microbiol Immunol Infect; 2016 Jun; 49(3):409-16. PubMed ID: 25315214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response.
    Park KH; Sawada T; Murakami T; Ishii Y; Yasuo M; Fuchinoue S; Goldenberg DM; Kubota K
    Am J Surg; 2012 Oct; 204(4):527-34. PubMed ID: 22658578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in Tanzania.
    Drabe CH; Vestergaard LS; Helleberg M; Nyagonde N; Rose MV; Francis F; Theilgaard OP; Asbjørn J; Amos B; Bygbjerg IC; Ruhwald M; Ravn P
    Am J Trop Med Hyg; 2016 Apr; 94(4):728-35. PubMed ID: 26834199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ATP-binding cassette transporters and calcineurin inhibitors: potential clinical implications.
    van Gelder T; Klupp J; Sawamoto T; Christians U; Morris RE
    Transplant Proc; 2001 May; 33(3):2420-1. PubMed ID: 11377580
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between pharmacokinetics and pharmacodynamics of calcineurin inhibitors in renal transplant patients.
    Albring A; Wendt L; Harz N; Engler H; Wilde B; Kribben A; Lindemann M; Schedlowski M; Witzke O
    Clin Transplant; 2015 Apr; 29(4):294-300. PubMed ID: 25557538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin inhibitors in pediatric renal transplant recipients.
    Filler G
    Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NFAT-regulated cytokine gene expression during tacrolimus therapy early after renal transplantation.
    Bremer S; Vethe NT; Skauby M; Kasbo M; Johansson ED; Midtvedt K; Bergan S
    Br J Clin Pharmacol; 2017 Nov; 83(11):2494-2502. PubMed ID: 28686294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic concentrations of calcineurin inhibitors do not deregulate glutathione redox balance in human renal proximal tubule cells.
    Ramazani Y; Knops N; Berlingerio SP; Adebayo OC; Lismont C; Kuypers DJ; Levtchenko E; van den Heuvel LP; Fransen M
    PLoS One; 2021; 16(4):e0250996. PubMed ID: 33930094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease.
    Brewin J; Mancao C; Straathof K; Karlsson H; Samarasinghe S; Amrolia PJ; Pule M
    Blood; 2009 Nov; 114(23):4792-803. PubMed ID: 19770360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.
    Staatz CE; Goodman LK; Tett SE
    Clin Pharmacokinet; 2010 Apr; 49(4):207-21. PubMed ID: 20214406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
    Kim S; Lee H; Kim H; Kim Y; Cho JE; Jin H; Kim DY; Ha SJ; Kang YA; Cho SN; Lee H
    J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple cytokines for the detection of
    Nausch N; Lundtoft C; Schulz G; Henckel H; Mayatepek E; Fleischer B; Marx FM; Jacobsen M
    Int J Tuberc Lung Dis; 2017 Mar; 21(3):270-277. PubMed ID: 28225337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic monitoring of calcineurin phosphatase activity in transplant patients treated with calcineurin inhibitors.
    Yano I
    Drug Metab Pharmacokinet; 2008; 23(3):150-7. PubMed ID: 18574318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study.
    Blauenfeldt T; Wagner D; Aabye M; Heyckendorf J; Lange B; Lange C; Ernst M; Ravn P; Duarte R; Morais C; Hoffmann M; Schoch OD; Dominguez J; Latorre I; Ruhwald M
    Tuberculosis (Edinb); 2016 May; 98():7-12. PubMed ID: 27156612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment.
    Mínguez S; Latorre I; Mateo L; Lacoma A; Diaz J; Olivé A; Domínguez J
    Clin Rheumatol; 2012 May; 31(5):785-94. PubMed ID: 22271230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of TGF-beta in organ transplantation might be due to rejection rather than calcineurin inhibitor medication.
    Wynn C; Pan F; Erickson L; Ebbs A; Kobayashi M; Jiang H
    Transplant Proc; 2002 Aug; 34(5):1387-9. PubMed ID: 12176408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.